L-carnitine
Also called: carnitine, acetyl-L-carnitine, propionyl-L-carnitine, levocarnitine
An amino acid-derived compound that transports long-chain fatty acids into mitochondria. The liver, kidneys and brain make it from lysine and methionine; red meat is the main dietary source. About 95% is stored in heart and skeletal muscle.
- Category
- Amino acid and protein
- Forms
- L-carnitine and acetyl-L-carnitine (main supplement forms); propionyl-L-carnitine
- Strongest evidence
- B Some positive trials
- Reviewed
- 2026-10-28
Class 1 Well studied in people. A 2024 meta-analysis (Diabetol Metab Syndr) pooled 21 RCTs (2,900 participants with impaired glucose tolerance or diabetes) of oral L-carnitine versus placebo or no L-carnitine; some trials added L-carnitine to orlistat, sibutramine or simvastatin given to both arms. [3]
Fact-checked 2026-10-28 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BBlood sugar and weight2 topics
BHeart and blood vessels1 topic
BHormones and reproduction1 topic
CBrain, mood and sleep1 topic
CMuscles and exercise1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Blood glucose control in type 2 diabetes or insulin resistance | B | A 2023 meta-analysis of 41 trials (about 2,900 participants) found lower fasting glucose, insulin resistance and HbA1c; ODS states larger trials are needed. [1] |
| Outcomes after acute myocardial infarction | B | A meta-analysis of 13 trials (3,629 adults) found lower all-cause mortality, ventricular arrhythmias and new angina, but no effect on heart failure or reinfarction. [1] |
| Body weight | B | A 2016 meta-analysis of 9 trials (911 participants) found an average 1.33 kg greater weight loss than placebo. [1] |
| Sperm quality and fertility in men | B | A 2022 Cochrane review (6 trials, 1,089 men) found improved sperm motility and concentration at some time points, but no effect on live birth or pregnancy rates. [1] |
| Athletic performance | C | Evidence is mixed: reviews found some benefits, such as lower lactate and faster recovery, while other studies showed no effect. [1] |
| Mild cognitive impairment and Alzheimer's disease (acetyl-L-carnitine) | C | A 2003 Cochrane review of 11 trials in Alzheimer’s disease found more people improved on clinical global impression with acetyl-L-carnitine at 12 and 24 weeks but not at 52 weeks, no benefit on objective measures, and no evidence to recommend routine use. [4] |
Main constituents: L-carnitine, acetyl-L-carnitine, propionyl-L-carnitine [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Supplements provide about 3 mg to 5,000 mg. Typical omnivorous diets provide about 24-145 mg/day; vegan diets about 1.2 mg/day. [1]
- For primary and secondary carnitine deficiency, ODS describes high doses of 20-200 mg/kg/day of supplemental carnitine, used under medical care. [1]
Upper limits
- No Dietary Reference Intakes or UL have been established; healthy people make enough carnitine and do not need it from food or supplements. [1]
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingHealth Canada monograph: ask a health care practitioner before use if pregnant or breastfeeding.
1 statement in the profile.
Details and sources - Interactions with medicines2 listed
Pivalate-conjugated antibiotics (such as pivampicillin); Anticonvulsants (valproic acid, phenobarbital, phenytoin, carbamazepine)
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications3 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsStated
Health Canada (monograph dated July 25, 2025), adults 18 and older: not to exceed 4 grams of L-carnitine per day (antioxidant use) or 1-4 grams per …
Details and sources
- Doses of about 3 g/day can cause nausea, vomiting, abdominal cramps, diarrhea and a fishy body odor. [1]
- Carnitine can cause muscle weakness in people with uremia and seizures in people with seizure disorders. [1]
- Gut bacteria convert unabsorbed carnitine to TMAO, which may increase cardiovascular disease risk; the implications are not well understood. [1]
Interactions
| With | What happens |
|---|---|
| Pivalate-conjugated antibiotics (such as pivampicillin) | Chronic use can deplete carnitine; no illness from this deficiency has been described. [1] |
| Anticonvulsants (valproic acid, phenobarbital, phenytoin, carbamazepine) | These drugs reduce blood carnitine levels. Intravenous L-carnitine may help in valproate toxicity, but the optimal regimen is not identified. [1] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- Absorption of supplemental L-carnitine is about 14-18%, compared with about 63-75% for carnitine from food. [1]
Regulatory status
- US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [2]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 3 entries naming carnitine (earliest NDI 248 submitted 2003-08-13; most recent NDI 769 submitted 2012-08-06). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P3]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test or examination of each dietary-ingredient component — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants an exemption petition under 111.75(a)(1)(ii). [P6]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- Absorption of supplemental L-carnitine is about 14-18%, compared with about 63-75% for carnitine from food; some research indicates that intestinal bacteria metabolize unabsorbed carnitine to TMAO and gamma-butyrobetaine. [P1]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- Health Canada (monograph dated July 25, 2025), adults 18 and older: not to exceed 4 grams of L-carnitine per day (antioxidant use) or 1-4 grams per day (muscle recovery and athletic support uses), in each case not to exceed 2 grams per single dose. [P2]
Pregnancy and breastfeeding
- Health Canada monograph: ask a health care practitioner before use if pregnant or breastfeeding. [P2]
Sources for this profile
- NIH Office of Dietary Supplements. Carnitine: Fact Sheet for Health Professionals (Updated: April 17, 2023), 2023-04-17. ods.od.nih.gov
- Health Canada, NNHPD. Monograph: L-Carnitine (date 2025-07-25), 2025-07-25. webprod.hc-sc.gc.ca
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1-142 (last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
- National Toxicology Program (NIEHS). Technical Reports list (checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75 What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
Sources
- NIH Office of Dietary Supplements. Carnitine: Fact Sheet for Health Professionals (Updated: April 17, 2023), 2023-04-17. ods.od.nih.gov
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (Content current as of 08/27/2026), 2026-08-27. fda.gov
- Gheysari R, et al. The effects of L-carnitine supplementation on cardiovascular risk factors in participants with impaired glucose tolerance and diabetes: a systematic review and dose-response meta-analysis. Diabetol Metab Syndr 2024;16(1):185 (PMID 39085907), 2024-07-31. pubmed.ncbi.nlm.nih.gov
- Hudson S, Tabet N. Acetyl-L-carnitine for dementia. Cochrane Database Syst Rev 2003;(2):CD003158 (PMID 12804452), 2003-04-22. pubmed.ncbi.nlm.nih.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in amino acid and protein: 5-HTP (5-hydroxytryptophan) · Beta-alanine · BPC-157 · Branched-chain amino acids (BCAAs) · Carnosine (L-carnosine) · Collagen peptides · Creatine · Glutathione · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.